GILD in the 13F filings
Gilead Sciences Inc · CUSIP 375558103
- Quarter end
- 31 Mar 2025
- the date the book describes
- Filed
- 5 Nov 2026
- latest of these filings; the earliest 12 May 2025
- Managers listing it
- 33
- at least, of 95 tracked, among listed positions
- Comparable managers
- 95
- filed both Q4 2024 and Q1 2025; 24 listed it in both
- Shares listed
- 285,291,788
- combined, among listed positions
- Reported value
- $32.0bn
- combined, at the quarter end
Among the 95 comparable managers: 21 buyers (opened or added shares) and 12 sellers (trimmed or exited), at least, among listed positions. Their net change in shares is not known from listed positions, because at least one of them lists it in only one of the two quarters.
Managers listing GILD in Q1 2025
33 of 33 holders
Largest increases and reductions, by shares
Increases
- Fidelity (FMR LLC)existing position · 58,542,842 shares now+18,223,410
- T. Rowe Price Associates Incexisting position · 14,703,103 shares now+11,156,382
- Holocene Advisors LPnew position · 2,307,871 shares now+2,307,871
- Man Group PLCexisting position · 1,664,588 shares now+791,409
- Citadel Advisors LLCexisting position · 5,373,962 shares now+678,073
Reductions
- Capital World Investorsexisting position · 53,547,901 shares now-18,158,461
- Wellington Management Group LLPexisting position · 27,358,967 shares now-8,300,040
- Capital Research Global Investorsexisting position · 54,610,370 shares now-3,335,858
- Invesco Ltdexisting position · 10,126,898 shares now-1,151,017
- Janus Henderson Group Ltdexisting position · 728,417 shares now-567,660
New positions and exits
New (6)
Exited (0)
No exit shown by a manager’s own filing.
Ownership over time
Tracked managers listing it, at least.
| Quarter | Holders | Reported value | Buyers | Sellers |
|---|---|---|---|---|
| Q2 2013 | 22 | $26.4bn | n.a. | n.a. |
| Q3 2013 | 20 | $31.7bn | n.a. | n.a. |
| Q4 2013 | 24 | $35.6bn | n.a. | n.a. |
| Q1 2014 | 26 | $30.7bn | n.a. | n.a. |
| Q2 2014 | 26 | $35.5bn | n.a. | n.a. |
| Q3 2014 | 28 | $40.8bn | n.a. | n.a. |
| Q4 2014 | 30 | $30.9bn | n.a. | n.a. |
| Q1 2015 | 32 | $31.9bn | n.a. | n.a. |
| Q2 2015 | 31 | $36.4bn | n.a. | n.a. |
| Q3 2015 | 31 | $27.6bn | n.a. | n.a. |
| Q4 2015 | 34 | $25.0bn | n.a. | n.a. |
| Q1 2016 | 35 | $18.5bn | n.a. | n.a. |
| Q2 2016 | 33 | $15.5bn | n.a. | n.a. |
| Q3 2016 | 30 | $12.9bn | n.a. | n.a. |
| Q4 2016 | 33 | $11.4bn | n.a. | n.a. |
| Q1 2017 | 33 | $9.9bn | n.a. | n.a. |
| Q2 2017 | 33 | $10.4bn | n.a. | n.a. |
| Q3 2017 | 27 | $12.4bn | n.a. | n.a. |
| Q4 2017 | 28 | $12.3bn | n.a. | n.a. |
| Q1 2018 | 32 | $14.0bn | n.a. | n.a. |
| Q2 2018 | 29 | $13.6bn | n.a. | n.a. |
| Q3 2018 | 29 | $15.6bn | n.a. | n.a. |
| Q4 2018 | 32 | $13.3bn | n.a. | n.a. |
| Q1 2019 | 32 | $14.9bn | n.a. | n.a. |
| Q2 2019 | 29 | $16.1bn | n.a. | n.a. |
| Q3 2019 | 30 | $13.9bn | n.a. | n.a. |
| Q4 2019 | 32 | $14.3bn | n.a. | n.a. |
| Q1 2020 | 28 | $17.0bn | n.a. | n.a. |
| Q2 2020 | 23 | $18.7bn | n.a. | n.a. |
| Q3 2020 | 25 | $14.2bn | n.a. | n.a. |
| Q4 2020 | 27 | $13.4bn | n.a. | n.a. |
| Q1 2021 | 24 | $14.5bn | n.a. | n.a. |
| Q2 2021 | 18 | $14.9bn | n.a. | n.a. |
| Q3 2021 | 20 | $16.4bn | n.a. | n.a. |
| Q4 2021 | 20 | $16.8bn | n.a. | n.a. |
| Q1 2022 | 28 | $13.2bn | n.a. | n.a. |
| Q2 2022 | 26 | $13.6bn | n.a. | n.a. |
| Q3 2022 | 24 | $13.3bn | n.a. | n.a. |
| Q4 2022 | 32 | $21.1bn | n.a. | n.a. |
| Q1 2023 | 27 | $21.8bn | n.a. | n.a. |
| Q2 2023 | 24 | $20.7bn | n.a. | n.a. |
| Q3 2023 | 24 | $20.0bn | n.a. | n.a. |
| Q4 2023 | 22 | $21.5bn | 10 | 11 |
| Q1 2024 | 30 | $20.3bn | 17 | 12 |
| Q2 2024 | 28 | $18.5bn | 15 | 14 |
| Q3 2024 | 29 | $24.2bn | 15 | 15 |
| Q4 2024 | 28 | $25.9bn | 14 | 14 |
| Q1 2025 | 33 | $32.0bn | 21 | 12 |
| Q2 2025 | 27 | $30.9bn | 18 | 10 |
| Q3 2025 | 23 | $29.4bn | 9 | 14 |
| Q4 2025 | 25 | $34.3bn | 18 | 19 |
| Q1 2026 | 25 | $38.5bn | 16 | 21 |
| Q2 2026 | 26 | $34.2bn | 22 | 16 |
Compare with…
Holders over time, buyers and sellers, and the managers holding both, side by side for up to four stocks.
GILD and AMGN →GILD and ARGX →GILD and RVMD →Choose a stock to compare with GILD →
How much of the picture this is
A 13F is a manager’s long US-listed equity book at a quarter end, filed up to 45 days later. It shows no shorts, cash, bonds or performance, and it is never today’s portfolio. Large books are listed to their largest positions, so a manager missing from this table may still hold a small position below that line. These are 95 tracked managers, not the institutional market.
Which funds own GILD, latest filings →Back to the 13F Explorer →